27 06, 2024

Micron Tech Tumbles 6% on Less Than Fantastic Forecast: 3 Reasons It’s STILL Time to Buy MU

By |2024-06-27T17:57:47+00:00June 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Micron Tech (MU) reported its fiscal Q3 earnings results alongside a forecast for the final quarter of the fiscal year, and shares slid 6% as investors were expecting more. Revenue came in at $6.81 billion for the quarter, which was a whopping 81% improvement year over year. Analysts were expecting $6.61 billion.  Meanwhile, earnings [...]

26 06, 2024

Navigating the Economic Tides: What Consumer Confidence Trends Mean for Your Investment Strategy

By |2024-06-26T18:21:43+00:00June 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , |

Are you feeling the economic uncertainty in the air? You're not alone. Recent data on consumer confidence paints a complex picture of the current economic landscape, with implications that could significantly impact your investment decisions. The latest Consumer Confidence Index has dipped to 100.4 in June from 101.3 in May. While this might seem [...]

26 06, 2024

FedEx Cost Cuts and Upbeat Outlook Send Shares 14% Higher: 3 Other Reasons to BUY FDX

By |2024-06-26T18:16:39+00:00June 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

It had been a tough past few months for FedEX (FDX) investors, who watched their positions plummet 14%. But shares have recovered all that and more today after the delivery company released positive 4th quarter results for fiscal 2024. Earnings came in at $5.94 per share, which was ahead of the analyst expectation of [...]

25 06, 2024

Analysts are Bullish on IBM, But is it Actually Time to Buy This Stock? 3 Things to Consider First

By |2024-06-25T16:32:10+00:00June 25th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Goldman Sachs analyst James Schneider helped send shares of International Business Machines (IBM) higher Monday with a bullish outlook on the company for the road ahead. He set a price target at $200 and says it’s time to buy this stock, which currently sits at $173. Schneider is bullish on the IT services segment [...]

24 06, 2024

Should You Buy Chipotle (CMG) Ahead of the 50-for-1 Stock Split? 3 Things to Consider

By |2024-06-24T17:47:49+00:00June 24th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

The 50-for-1 stock split of Chipotle Mexican Grill (CMG) is scheduled to go live tomorrow (Tuesday, 6/25) after the market closes. As one of the largest stock splits in the history of the NYSE, all eyes are on the stock as the clock ticks down. Those who are new to the concept of stock [...]

24 06, 2024

Last Week’s Market Recap: Tech Gains and Mixed Results Define the Week

By |2024-06-24T14:47:18+00:00June 24th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , |

Monday: Tech Gains Propel Markets Higher Wall Street kicked off the week on a positive note, largely driven by strong performances in the technology sector. The Dow Jones Industrial Average climbed 0.5%, the S&P 500 rose by 0.8%, and the tech-heavy Nasdaq Composite led the pack with a 1.0% increase. The bullish sentiment in [...]

24 06, 2024

THE PRESIDENTIAL ELECTION CYCLE AND THE FED

By |2024-06-24T14:32:04+00:00June 24th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , , |

Written by: Angela Akers As they have done for the last year, the Federal Reserve moved last week to leave interest rates unchanged at the elevated rate of 5.25% – 5.50% and signaled only one cut this year. That same morning, the May Consumer Price Index was released, coming in at a lower-than-expected increase [...]

21 06, 2024

Sarepta Shoots up 36% on New Drug Breakthrough for DMD: 2 Reasons to Consider Buying SRPT

By |2024-06-21T17:25:58+00:00June 21st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Sarepta Therapeutics (SRPT) announced late Thursday it had gained FDA approval for its treatment designed to target a rare genetic disease known as Duchenne muscular dystrophy (DMD). This condition causes progressive weakness, predominantly in boys, and is caused by a lack of key protein dystrophin. It has no known cure at this time. The [...]

20 06, 2024

Accenture Jumps 7% on Upbeat Forecast Despite Earnings Miss: Does AI Growth Make ACN a BUY?

By |2024-06-20T18:12:48+00:00June 20th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Accenture (ACN) delivered fiscal Q3 results Thursday morning right before the market opened, and despite a miss on the top and bottom lines, the company’s forecast for the road ahead was enough to send shares nearly 7% higher. Revenue for the third quarter was disappointing at just $16.47 billion, narrowly below the $16.53 billion [...]

19 06, 2024

Dell Was Down After Disappointing Earnings, But the Road to Recovery is Underway: Time to Buy?

By |2024-06-19T17:36:44+00:00June 19th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Just last month Dell Technologies (DELL) reported first-quarter earnings that fell short of Wall Street’s expectations, taking the stock down from its all-time high of $179/share. It fell more than 30% in just a few days, eroding market cap and scaring investors out of their positions.  The issue was that despite AI growth fueling [...]

Go to Top